PRE Q3 2021 Earnings — Prenetics Global Limited Revenue & Financial Results | Market Cap Arena

PREPrenetics Global Limited

$292M

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$75M+188.0% YoY

Gross Profit

$26M34.5% margin

Operating Income

-$5M-7.2% margin

Net Income

-$80M-107.7% margin

EPS (Diluted)

$-21.29

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

-$72,018

Free Cash Flow

-$72,020

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$340M

Total Liabilities

$34M

Stockholders' Equity

$306M

Cash & Equivalents

$227,157

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$26M	+188.0%
Gross Profit	$26M	$14M	+86.0%
Operating Income	-$5M	$7M	-174.5%
Net Income	-$80M	$9M	-970.1%